Lithium carbonate

This classification denotes an antipsychotic agent with the molecular formula CO3.2Li, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2BMD2GNA4V, chemically known as lithium carbonate, rb2co3 but generally known as lithium carbonate, which bears US NIH Compound Identifier 767. European Medicines Agency schedules Lithium carbonate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14375MIG. Most nations schedule lithium carbonate under HS 28369100 and SITC 52379. As of Q4 2014, LITHIUM CARBONATE remains the US FDA Preferred Term for this commodity. Lithium carbonate bears US NLM identifiers UMLS ID C0085217 and NCI Concept Code C1318. SMILES: OC(=O)O.